Determining the Ideal Strategy for Ventilator-associated Pneumonia Prevention. Cost-Benefit Analysis.

Westyn Branch-EllimanSharon B WrightMichael D Howell

Published in: American journal of respiratory and critical care medicine (2015)

Despite their infrequent use, current data suggest that the use of prophylactic probiotics and subglottic endotracheal tubes are cost-effective for preventing VAP from the societal and hospital perspectives.

Keyphrases

healthcare
big data
acute care

adverse drug
emergency department
machine learning

data analysis
intensive care unit

artificial intelligence
community acquired pneumonia